Loading…
Correspondence to editorial on "Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study"
According to the WHO’s 2024 Global Hepatitis Report [5], between 2020–2022, the number of new hepatitis B cases decreased from 1.5 to 1.2 million, while the death rate increased from 820,000 to 1.1 million. The diagnosis and treatment rates of hepatitis C were 36% and 13%, respectively. [...]a huge...
Saved in:
Published in: | Clinical and molecular hepatology 2024, 30(4), , pp.997-999 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | According to the WHO’s 2024 Global Hepatitis Report [5], between 2020–2022, the number of new hepatitis B cases decreased from 1.5 to 1.2 million, while the death rate increased from 820,000 to 1.1 million. The diagnosis and treatment rates of hepatitis C were 36% and 13%, respectively. [...]a huge scale-up of hepatitis diagnosis and treatment is required to achieve the WHO target. [...]it is necessary to make a collective effort to accelerate progress and address the gaps in the coverage of testing and treatment of hepatitis B and C to achieve the WHO target. |
---|---|
ISSN: | 2287-2728 2287-285X 2287-285X |
DOI: | 10.3350/cmh.2024.0588 |